Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1982 Dec 1;207(3):381–388. doi: 10.1042/bj2070381

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.

J J Holst
PMCID: PMC1153876  PMID: 7165698

Abstract

Enteroglucagon (II) was isolated from extracts of pig ileum mucosa by repeated gel filtrations, and its immunochemical and chromatographic characteristics were compared with those of a synthetic peptide corresponding to the 33-69 sequence of pig glicentin, before and after digestion with trypsin or trypsin followed by carboxypeptidase B, by using five region-specific assays covering most of the glicentin sequence. Enteroglucagon (II) and the synthetic peptide behave identically under three different conditions of chromatography as determined with all five assays (including a highly specific radioreceptor assay), and gave rise to similar fragments after enzyme digestion. It was therefore concluded that enteroglucagon (II) and the 33-69 sequence of glicentin are most probably identical.

Full text

PDF
381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Holst J. J. A radioreceptor-assay for glucagon: binding of enteroglucagon to liver plasma membranes. Diabetologia. 1975 Jun;11(3):211–219. doi: 10.1007/BF00422324. [DOI] [PubMed] [Google Scholar]
  2. Holst J. J. Evidence that glicentin contains the entire sequence of glucagon. Biochem J. 1980 May 1;187(2):337–343. doi: 10.1042/bj1870337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Holst J. J. Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity. Diabetologia. 1977 Apr;13(2):159–169. doi: 10.1007/BF00745145. [DOI] [PubMed] [Google Scholar]
  4. Holst J. J. Extrapancreatic glucagons. Digestion. 1978;17(2):168–190. doi: 10.1159/000198107. [DOI] [PubMed] [Google Scholar]
  5. Jorgensen K. H., Larsen U. D. Purification of 125 I-glucagon by anion exchange chromatography. Horm Metab Res. 1972 May;4(3):223–224. doi: 10.1055/s-0028-1097092. [DOI] [PubMed] [Google Scholar]
  6. Korányi L., Péterfy F., Szabó J., Török A., Guóth M., Tamás G., Jr Evidence for transformation of glucagon-like immunoreactivity of gut into pancreatic glucagon in vivo. Diabetes. 1981 Sep;30(9):792–794. doi: 10.2337/diab.30.9.792. [DOI] [PubMed] [Google Scholar]
  7. Moody A. J., Holst J. J., Thim L., Jensen S. L. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Nature. 1981 Feb 5;289(5797):514–516. doi: 10.1038/289514a0. [DOI] [PubMed] [Google Scholar]
  8. Newgard C. B., Holst J. J. Heterogeneity of somatostatin like immunoreactivity (SLI) in extracts of porcine, canine and human pancreas. Acta Endocrinol (Copenh) 1981 Dec;98(4):564–572. doi: 10.1530/acta.0.0980564. [DOI] [PubMed] [Google Scholar]
  9. Sundby F., Jacobsen H., Moody A. J. Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity. Horm Metab Res. 1976 Sep;8(5):366–371. doi: 10.1055/s-0028-1093615. [DOI] [PubMed] [Google Scholar]
  10. Thim L., Moody A. J. The primary structure of porcine glicentin (proglucagon). Regul Pept. 1981 May;2(2):139–150. doi: 10.1016/0167-0115(81)90007-0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES